Delivery Order SPE2DB22D2005-SPE2DB24FJFM4
- Not listed
- This federal contract award, valued at $2,155.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a completion date of February 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has extensive...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,404,006 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,720.56 and is a Firm Fixed Price Delivery Order, with a period of performance through November 13, 2024....
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,652.83 and a period of performance through May 30, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM5K9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567116736 units of Ondansetron ODT 4 mg tablets, a pharmaceutical product used for the treatment of nausea and vomiting. The award has a ceiling value of $5,975.16 and is a firm fixed-price delivery order contract, with a completion date of February 3, 2025. The contract does not have a...
- The federal contract award, with ID SPE2DB22D3004|SPE2DB25FPJ74, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,724.08, is a Delivery Order with a Firm Fixed Price pricing type. It is for the supply of Ondansetron ODT 4 MG Tablet 30S, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen...
- This federal contract award, with an ID of SPE2DB22D3011|SPE2DB25FP8MY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of ondansetron ODT 4 mg tablets, a prescription medication commonly used to treat nausea and vomiting. The contract has a ceiling value of $7,309.53 and is a firm fixed-price delivery order with a completion date of January 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, with an identifier of SPE2DB22D2211|SPE2DB24FNYD0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 MG Tablets, a medication commonly used to treat nausea and vomiting. The award has a ceiling value of $2,958.40 and a completion date of July 17, 2024. This contract is a delivery order, with a firm fixed-price...
- This federal contract award, with the ID SPE2DB24D1007|SPE2DB24FBZWF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,822.83 and is a firm fixed-price delivery order type, with a completion date of July 11, 2024. This award is part of a...
- This federal contract award, with ID SPE2DB20D7066|SPE2DB24FC2FB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $23,519.07 and is a firm fixed-price delivery order, with a completion date of June 5, 2024. This contract award is part of a...
- This federal contract award, with ID SPE2DB20D3505|SPE2DB24FT3P8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The award has a ceiling value of $8,168.72 and an ultimate completion date of November 17, 2023. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJFM4Delivery Order
This federal contract award, with an ID of SPE2DB22D2005|SPE2DB24FJFM4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $2,025.19 and an ultimate completion date of December 14, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/13/23 |